Immupharma Share Discussion Threads

[bloomberg2] 24/8/2022 11:41

https://youtu.be/TAw39iaUYno

[neo26] 24/8/2022 11:17

Once in phase 3 imm should have mkt cap over 50m.As is progresses phase 3 should be over 150m to 200m.Fully funded phase 3, lets see...

[1bond] 24/8/2022 11:00

The odds are very much in favour of getting FDA approval: PK study is done, met all its endpoints and satisfied the requirements. The FDA response is by way of a written response, type C which I understand is a further positive signal and usual at this stage. We then have a fully funded undervalued Phase 111 asset. Of course if the share price spikes there will be sellers, but once they are out of the way, we should see positive share price momentum as the company starts announcing patient recruitment etc.

[dillydally2] 24/8/2022 10:20

Master fund finance hey death spiral financiers

[neo26] 24/8/2022 10:15

SportbillyWell last year fda requested a pk study, the pk study was done earliar this year and passed with flying colors.Balls in fda court..

[1bond] 24/8/2022 10:00

Then sportbilly1976, "Houston, we have a problem!!

[sportbilly1976] 24/8/2022 09:53

Neo,

...and if FDA don't approve?

[nobbygnome] 24/8/2022 09:37

For the record just bought a few more at 6.6…

[neo26] 24/8/2022 09:11

The fda decision is whether trials can commence on phase 3.The fda required pk studies which avion completed successfully.Like i said previously if fda approves phase 3 the share price is double figures.

[mudbath] 24/8/2022 09:09

Anyone spot Nobby(Ho hum)gnome ?

[sportbilly1976] 24/8/2022 09:02

most will have (rightly) de-risked the day before the announcement

[neo26] 23/8/2022 15:38

Consolidating well.Can see this in double figure by tuesday..

[nobbygnome] 23/8/2022 09:43

The irony is that most likely neo is doing exactly the same as me but he/she just doesn’t admit it. He will be out on any spike and move on to the next ramp. Ho hum…

[neo26] 23/8/2022 09:39

Volume is very good...

[nobbygnome] 23/8/2022 09:31

Now that’s some good ramping…

[neo26] 23/8/2022 09:27

Remember 2 peer companies with phase 3 drug valued at 57m and 111m.Here we are around 25m, we have phase 3 fully funded.Its undervalued to its peers, finally turning the corner.I can see 15p on approval next week.

[nobbygnome] 23/8/2022 09:15

Relentless buying! I think this has to melt up today

[nobbygnome] 23/8/2022 09:12

>> ACT

Yes

[nobbygnome] 23/8/2022 09:11

LOL strangely I’ve actually called it correctly all the way through! But hey, don’t let the truth get in the way of a good story…..

[arlington chetwynd talbott] 23/8/2022 09:11

So you think the approval will be announced?

[neo26] 23/8/2022 09:06

NoddyWalk away, i know u lost in past.

[nobbygnome] 23/8/2022 09:04

There is clearly some good ramping going on somewhere. I think a Twitter ramp was mentioned yesterday

[nobbygnome] 23/8/2022 09:03

>> ACT

As previously stated, it’s purely a punt on a spike when the approval is announced. So far it’s been a good strategy. However ultimately the drug won’t work IMHO, although of course we won’t find out for another 2 and a half years or so

[geraldus] 23/8/2022 09:00

Bank holiday here Monday.